| Unbound MEDLINE results for: | Bookmark this site | | Articles related to 18559790 [Unique ID], provided by the PubMed system | |
| |
|
| | 1 - 10 of 102 journal articles in the PubMed database | Email to a friend | | |
| Kong HH, Sibaud V, Chanco Turner ML, et al. Sorafenib-induced eruptive melanocytic lesions. [Case Reports, Letter] Arch Dermatol 2008 Jun; 144(6):820-2. Full Citation | Publisher Full Text | Find Related Articles | | Hong DS, Reddy SB, Prieto VG, et al. Multiple squamous cell carcinomas of the skin after therapy with sorafenib combined with tipifarnib. [Case Reports, Journal Article, Research Support, N.I.H., Extramural] Arch Dermatol 2008 Jun; 144(6):779-82. Abstract | Full Citation | Publisher Full Text | Find Related Articles | | Lai SE, Kuzel T, Lacouture ME Hand-foot and stump syndrome to sorafenib. [Case Reports, Journal Article] J Clin Oncol 2007 Jan 20; 25(3):341-3. Full Citation | Publisher Full Text | Find Related Articles | | Autier J, Escudier B, Wechsler J, et al. Prospective study of the cutaneous adverse effects of sorafenib, a novel multikinase inhibitor. [Clinical Trial, Phase III, Journal Article, Multicenter Study, Randomized Controlled Trial, Research Support, Non-U.S. Gov't] Arch Dermatol 2008 Jul; 144(7):886-92. Abstract | Full Citation | Publisher Full Text | Find Related Articles | | Beldner M, Jacobson M, Burges GE, et al. Localized Palmar Plantar Epidermal Hyperplasia: A Previously Undefined Dermatologic Toxicity to Sorafenib. [JOURNAL ARTICLE] Oncologist 2007; 12(10):1178-1182. Abstract | Full Citation | | Lountzis NI, Maroon MS Sorafenib-induced palmoplantar hyperkeratosis. [Journal Article] J Drugs Dermatol 2008 Jun; 7(6):588-9. Abstract | Full Citation | Find Related Articles | | Ratain MJ, Eisen T, Stadler WM, et al. Phase II placebo-controlled randomized discontinuation trial of sorafenib in patients with metastatic renal cell carcinoma. [Clinical Trial, Phase II, Journal Article, Multicenter Study, Randomized Controlled Trial] J Clin Oncol 2006 Jun 1; 24(16):2505-12. Abstract | Full Citation | Publisher Full Text | Find Related Articles | | Yang CH, Lin WC, Chuang CK, et al. Hand-foot skin reaction in patients treated with sorafenib: a clinicopathological study of cutaneous manifestations due to multitargeted kinase inhibitor therapy. [JOURNAL ARTICLE] Br J Dermatol 2007 Dec 6. Abstract | Full Citation | Find Related Articles | | Bhojani N, Jeldres C, Patard JJ, et al. Toxicities Associated with the Administration of Sorafenib, Sunitinib, and Temsirolimus and Their Management in Patients with Metastatic Renal Cell Carcinoma. [JOURNAL ARTICLE] Eur Urol 2007 Nov 26. Abstract | Full Citation | Find Related Articles |  |
|
| | Advertise on this site.
|